Evidence map›Paper›PMID 29326598›Full record

ReviewFrontiers in physiology2017

Connexins in the Central Nervous System: Physiological Traits and Neuroprotective Targets.

Nunzio Vicario, Agata Zappalà, Giovanna Calabrese, Rosario Gulino, Carmela Parenti, Massimo Gulisano, Rosalba Parenti

Abstract readReview
In one paragraph

Review in Frontiers in physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Article
  3. Membrane protein structure and dynamics probed by MicroED.Biochemical Society transactions · 2026
    Review
  4. Article
  5. Article
  6. Connexin-Pannexin duality in glioblastoma.Cell and tissue research · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. CaMKII and CaCell biology and toxicology · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nunzio VicarioSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Agata ZappalàSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Giovanna CalabreseSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Rosario GulinoSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Carmela ParentiDepartment of Drug Sciences, University of Catania, Catania, Italy.
Massimo GulisanoSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Rosalba ParentiSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-to-cell interaction and cell-to-extracellular environment communication are emerging as new therapeutic targets in neurodegenerative disorders. Dynamic expression of connexins leads to distinctive hemichannels and gap junctions, characterized by cell-specific conduction, exchange of stimuli or metabolites, and particular channel functions. Herein, we briefly reviewed classical physiological traits and functions of connexins, hemichannels, and gap junctions, in order to discuss the controversial role of these proteins and their mediated interactions during neuroprotection, with a particular focus on Cx43-based channels. We pointed out the contribution of connexins in neural cells populations during neurodegenerative processes to explore potential neuroprotective therapeutic applications.

Indexed as

connexingap junctionhemichannelneurodegenerationneuroprotection

Identifiers

PMID29326598
PMCPMC5741605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.